Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 4
1990 1
1991 2
1992 3
1993 3
1994 4
1995 3
1996 3
1997 4
1998 5
1999 6
2000 8
2001 7
2002 10
2003 12
2004 6
2005 17
2006 13
2007 7
2008 1
2009 3
2010 6
2011 4
2012 6
2013 4
2014 2
2015 3
2016 5
2017 4
2018 8
2019 5
2020 4
2021 2
Text availability
Article attribute
Article type
Publication date

Search Results

160 results
Results by year
Filters applied: . Clear all
Page 1
Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study.
Noordman BJ, Spaander MCW, Valkema R, Wijnhoven BPL, van Berge Henegouwen MI, Shapiro J, Biermann K, van der Gaast A, van Hillegersberg R, Hulshof MCCM, Krishnadath KK, Lagarde SM, Nieuwenhuijzen GAP, Oostenbrug LE, Siersema PD, Schoon EJ, Sosef MN, Steyerberg EW, van Lanschot JJB; SANO study group. Noordman BJ, et al. Among authors: valkema r. Lancet Oncol. 2018 Jul;19(7):965-974. doi: 10.1016/S1470-2045(18)30201-8. Epub 2018 Jun 1. Lancet Oncol. 2018. PMID: 29861116
Neoadjuvant chemoradiotherapy for resectable oesophageal cancer.
Eyck BM, van der Wilk BJ, Lagarde SM, Wijnhoven BPL, Valkema R, Spaander MCW, Nuyttens JJME, van der Gaast A, van Lanschot JJB. Eyck BM, et al. Among authors: valkema r. Best Pract Res Clin Gastroenterol. 2018 Oct-Dec;36-37:37-44. doi: 10.1016/j.bpg.2018.11.007. Epub 2018 Nov 22. Best Pract Res Clin Gastroenterol. 2018. PMID: 30551855 Review.
Combining brentuximab vedotin with dexamethasone, high-dose cytarabine and cisplatin as salvage treatment in relapsed or refractory Hodgkin lymphoma: the phase II HOVON/LLPC Transplant BRaVE study.
Kersten MJ, Driessen J, Zijlstra JM, Plattel WJ, Morschhauser F, Lugtenburg PJ, Brice P, Hutchings M, Gastinne T, Liu R, Burggraaff CN, Nijland M, Tonino SH, Arens AIJ, Valkema R, van Tinteren H, Lopez-Yurda M, Diepstra A, De Jong D, Hagenbeek A. Kersten MJ, et al. Among authors: valkema r. Haematologica. 2021 Apr 1;106(4):1129-1137. doi: 10.3324/haematol.2019.243238. Haematologica. 2021. PMID: 32273476 Free PMC article.
Towards an Organ-Sparing Approach for Locally Advanced Esophageal Cancer.
van der Wilk BJ, Eyck BM, Spaander MCW, Valkema R, Lagarde SM, Wijnhoven BPL, van Lanschot JJB. van der Wilk BJ, et al. Among authors: valkema r. Dig Surg. 2019;36(6):462-469. doi: 10.1159/000493435. Epub 2018 Sep 18. Dig Surg. 2019. PMID: 30227434 Free PMC article. Review.
Peptide receptor radionuclide therapy.
Krenning EP, Kwekkeboom DJ, Valkema R, Pauwels S, Kvols LK, De Jong M. Krenning EP, et al. Among authors: valkema r. Ann N Y Acad Sci. 2004 Apr;1014:234-45. doi: 10.1196/annals.1294.026. Ann N Y Acad Sci. 2004. PMID: 15153440 Review.
Accuracy of 18F-FDG PET/CT in Predicting Residual Disease After Neoadjuvant Chemoradiotherapy for Esophageal Cancer.
Valkema MJ, Noordman BJ, Wijnhoven BPL, Spaander MCW, Biermann K, Lagarde SM, Bennink RJ, Schreurs WMJ, Roef MJ, Hobbelink MGG, Janssen MJR, Graven LH, van Lanschot JJB, Valkema R. Valkema MJ, et al. Among authors: valkema r. J Nucl Med. 2019 Nov;60(11):1553-1559. doi: 10.2967/jnumed.118.224196. Epub 2019 Mar 15. J Nucl Med. 2019. PMID: 30877177 Free article. Clinical Trial.
Active Surveillance Versus Immediate Surgery in Clinically Complete Responders After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Multicenter Propensity Matched Study.
van der Wilk BJ, Noordman BJ, Neijenhuis LKA, Nieboer D, Nieuwenhuijzen GAP, Sosef MN, van Berge Henegouwen MI, Lagarde SM, Spaander MCW, Valkema R, Biermann K, Wijnhoven BPL, van der Gaast A, van Lanschot JJB, Doukas M, Nikkessen S, Luyer M, Schoon EJ, Roef MJ, van Lijnschoten I, Oostenbrug LE, Riedl RG, Gisbertz SS, Krishnadath KK, Bennink RJ, Meijer SL; Collaborators:. van der Wilk BJ, et al. Among authors: valkema r. Ann Surg. 2019 Oct 4. doi: 10.1097/SLA.0000000000003636. Online ahead of print. Ann Surg. 2019. PMID: 31592898
160 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page